Group 1 - LiveOne (LVO) shares have increased by 0.6% over the past four weeks, closing at $5.16, with a mean price target of $11.5 indicating a potential upside of 122.9% [1] - The mean estimate consists of four short-term price targets with a standard deviation of $1.91, where the lowest estimate of $10.00 suggests a 93.8% increase, and the highest estimate of $14.00 indicates a 171.3% surge [2] - Analysts show strong agreement on LVO's ability to report better earnings, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] Group 2 - Over the last 30 days, the Zacks Consensus Estimate for LVO's current year earnings has risen by 10.2%, with two estimates moving higher and no negative revisions [12] - LVO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While the consensus price target may not be entirely reliable, the implied direction of price movement appears to be a useful guide for investors [14]

Core Viewpoint - Vicor (VICR) shows potential for significant upside, with a mean price target of $208.75 indicating a 28.3% increase from the current price of $162.67 [1] Price Targets - The average price target consists of four estimates ranging from a low of $180.00 to a high of $230.00, with a standard deviation of $23.23, suggesting a variability in analyst estimates [2] - The lowest estimate indicates a 10.7% increase, while the highest suggests a 41.4% upside [2] Analyst Consensus and Earnings Estimates - Analysts are increasingly optimistic about Vicor's earnings prospects, as indicated by a strong agreement in revising EPS estimates higher, which correlates with potential stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 8.1%, with no negative revisions [12] Zacks Rank - Vicor currently holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] Price Movement Guidance - While consensus price targets may not be entirely reliable, the direction they imply appears to be a useful guide for potential price movement [14]

Core Viewpoint - Oric Pharmaceuticals, Inc. (ORIC) has seen a 22% increase in share price over the past four weeks, closing at $13.4, with a mean price target of $21.23 indicating a potential upside of 58.4% according to Wall Street analysts [1] Price Targets and Analyst Estimates - The mean estimate consists of 13 short-term price targets with a standard deviation of $3.9, where the lowest estimate is $15.00 (11.9% increase) and the highest is $25.00 (86.6% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, indicating a more reliable consensus [2][9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about ORIC's earnings prospects, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 9.2%, with five estimates moving higher and no negative revisions [12] Zacks Rank and Investment Potential - ORIC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While the consensus price target may not be entirely reliable, the implied direction of price movement appears to be a useful guide for investors [14]

Core Viewpoint - TAL Education (TAL) shows potential for significant upside, with a mean price target of $15.85 indicating a 44.6% increase from its current price of $10.96 [1] Price Targets - The average price target consists of seven estimates ranging from a low of $11.54 to a high of $18.00, with a standard deviation of $2.19, suggesting variability in analyst predictions [2] - The lowest estimate indicates a 5.3% increase, while the highest suggests a 64.2% upside [2] - A low standard deviation indicates a higher agreement among analysts regarding price movement [2][9] Analyst Sentiment - Analysts are increasingly optimistic about TAL's earnings prospects, as evidenced by a trend of upward revisions in EPS estimates [11] - Over the past 30 days, three estimates have been revised higher, leading to a 42.5% increase in the Zacks Consensus Estimate for the current year [12] - TAL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be prudent, as analysts' ability to set accurate targets has been questioned [3][7] - Analysts often set optimistic targets due to business incentives, which can lead to inflated price expectations [8] - While price targets should not be ignored, they should be approached with skepticism and not be the sole basis for investment decisions [10]

Core Viewpoint - A10 Networks (ATEN) has shown a recent price increase and analysts suggest significant upside potential based on price targets, with a mean target indicating a 28.8% increase from the current price [1]. Price Targets - The average of five short-term price targets ranges from a low of $22.00 to a high of $28.00, with a standard deviation of $2.3, indicating variability among analysts [2]. - The lowest estimate suggests a 16.2% increase, while the highest points to a 47.8% upside [2]. Analyst Consensus and Earnings Estimates - Analysts are increasingly optimistic about ATEN's earnings prospects, as indicated by a trend of higher EPS estimate revisions [4][11]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 2.8%, with one estimate moving higher and no negative revisions [12]. Zacks Rank - ATEN currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Price Movement Implications - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14].

Group 1 - Trevi Therapeutics, Inc. (TRVI) shares have increased by 6.5% over the past four weeks, closing at $10.64, with a mean price target of $21.5 indicating a potential upside of 102.1% [1] - The mean estimate consists of 12 short-term price targets with a standard deviation of $3.26, where the lowest estimate is $16.00 (50.4% increase) and the highest is $27.00 (153.8% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as indicated by a 0.7% increase in the Zacks Consensus Estimate for the current year [11][12] Group 2 - TRVI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside [13] - While consensus price targets are often viewed as important, they should be approached with skepticism due to historical inaccuracies in predicting actual stock price movements [3][10] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9]

Core Viewpoint - Kforce (KFRC) has shown an 8.3% increase in stock price over the past four weeks, with a mean price target of $45.13 indicating a potential upside of 27.9% from the current price of $35.28 [1] Price Targets - The average price target for KFRC ranges from a low of $34.50 to a high of $71.00, with a standard deviation of $17.31, indicating variability in analyst estimates [2] - The lowest estimate suggests a decline of 2.2%, while the highest indicates a potential upside of 101.3% [2] - A low standard deviation signifies greater agreement among analysts regarding price movement [9] Analyst Sentiment - Analysts are optimistic about KFRC's earnings prospects, as indicated by upward revisions in EPS estimates, which historically correlate with stock price movements [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 0.2%, with one estimate moving higher and no negative revisions [12] Zacks Rank - KFRC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable indicator of the extent of KFRC's potential gains, it does provide a directional guide for price movement [14]

Core Viewpoint - Safehold (SAFE) shares have increased by 1.8% over the past four weeks, closing at $14.01, with a potential upside of 39.9% based on Wall Street analysts' mean price target of $19.6 [1] Price Targets and Analyst Estimates - The mean estimate consists of 10 short-term price targets with a standard deviation of $5.44, indicating variability among analysts; the lowest estimate is $14.00 (0.1% decline), while the highest is $28.00 (99.9% increase) [2] - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual stock price movements [7] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price direction, serving as a starting point for further research [9] Earnings Estimates and Analyst Agreement - Strong agreement among analysts in revising earnings per share (EPS) estimates upward supports the expectation of stock upside, as trends in earnings estimate revisions correlate with near-term stock price movements [11] - Over the past 30 days, one estimate has increased, leading to a 4% rise in the Zacks Consensus Estimate for the current year [12] - SAFE holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] Conclusion on Price Movement - While consensus price targets may not reliably indicate the extent of SAFE's potential gains, the implied direction of price movement appears to be a useful guide [14]

Core Viewpoint - Mission Produce, Inc. (AVO) shows potential for significant upside, with a mean price target of $17.33 indicating a 38.1% increase from the current trading price of $12.55 [1] Price Targets and Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $0.58, where the lowest estimate is $17.00 (35.5% increase) and the highest is $18.00 (43.4% increase) [2] - Analysts' price targets can be misleading, as empirical research suggests they rarely indicate actual stock price movements [7][10] Earnings Estimates - Analysts are optimistic about AVO's earnings prospects, with a strong consensus on higher EPS estimates, which historically correlates with stock price movements [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 57.5%, with one estimate moving higher and no negative revisions [12] Analyst Rankings - AVO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13]

Core Viewpoint - Galaxy Digital Inc. (GLXY) has shown a significant price increase of 42.1% over the past four weeks, with a mean price target of $48.63 indicating a potential upside of 52% from the current trading price of $31.99 [1] Price Targets and Analyst Estimates - The mean estimate consists of 14 short-term price targets with a standard deviation of $9.06, suggesting variability in analyst predictions. The lowest estimate is $24.00 (25% decline), while the highest is $60.00 (87.6% increase) [2] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Optimism - Analysts are optimistic about GLXY's earnings prospects, as indicated by a positive trend in earnings estimate revisions. The Zacks Consensus Estimate for the current year has increased by 28.5% over the last 30 days, with one estimate moving higher and no negative revisions [11][12] - GLXY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside in the near term [13] Caution on Price Targets - While price targets are often sought after by investors, they can be misleading. Empirical research shows that price targets rarely indicate the actual direction of a stock's price [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]